Zenith Health Care Ltd.
BSE: ZENITHHE · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Zenith Health Care Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Zenith Healthcare Limited is an Ahmedabad-based pharmaceutical company specialising in the manufacturing and marketing of finished formulations. Its portfolio includes antibiotics, analgesics, and gastrointestinal treatments, delivered through various dosage forms such as tablets, capsules, and injectables.
Business Model
The company generates revenue through the sale of its own branded pharmaceutical products and by providing contract manufacturing services to other pharmaceutical firms. It leverages a manufacturing facility to serve both domestic and international markets.
Growth Outlook
Growth is expected to be driven by the expansion of its generic medicine distribution network and the strengthening of its export business in developing regions. The company continues to focus on maintaining quality standards to support these market initiatives.
Key Risks
- Regulatory Compliance. The company faces risks related to stringent quality standards and potential regulatory audits in both domestic and international markets.
- Market Competition. As a small-cap entity, the company operates in a highly competitive pharmaceutical sector with significant pressure on pricing and margins.
- Export Dependency. Fluctuations in demand or geopolitical instability in developing regions could adversely impact the company's export-oriented revenue streams.
- Raw Material Costs. Volatility in the prices of active pharmaceutical ingredients and other raw materials may affect manufacturing costs and profitability.
Start your research today
Unlock AI insights, financials, peers and live data on Zenith Health Care Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹11 Cr
TTM · standalone
NET PROFIT
₹0.72 Cr
TTM · standalone
EPS
₹0.14
TTM · standalone
RETURN ON EQUITY
9.7%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
12.4%
TTM · standalone
P/E
22.5x
Q4 FY26 · standalone
EV/EBITDA
14.3x
Q4 FY26 · standalone
EBITDA MARGIN
11.2%
TTM · standalone
NET PROFIT MARGIN
13.0%
Q4 FY26 · standalone
DEBT TO EQUITY
0.0x
Q4 FY26 · standalone
Peers · Pharmaceuticals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Zenith Health Care Ltd.ZENITHHE | ₹17 Cr | 22.50 | 14.35 | -7.2% | 11.2% | 9.7% | 12.4% | -25.2% |
TranschemTRANSCHEM | ₹502 Cr | 75.62 | 52.99 | -100.0% | 177.7% | 8.3% | 10.6% | +600.8% |
Albert DavidALBERTDAVD | ₹501 Cr | 21.67 | 13.19 | 11.4% | 11.0% | 5.8% | 7.5% | +10.3% |
Haleos Labs LimitedHALEOSLABS | ₹457 Cr | 28.51 | 12.83 | -3.1% | 13.6% | 7.4% | 10.3% | — |
Medicamen BiotecMEDICAMEQ | ₹434 Cr | 43.00 | 19.76 | 24.7% | 11.3% | 4.1% | 6.2% | +5.9% |
Jenburkt Pharmaceuticals LimitedJENBURPH | ₹420 Cr | 12.30 | 8.20 | — | 30.0% | 16.7% | 21.5% | -15.2% |
As of Q4 FY26
Financials
Zenith Health Care Ltd.
BSE: ZENITHHE · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Zenith Health Care Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Zenith Healthcare Limited is an Ahmedabad-based pharmaceutical company specialising in the manufacturing and marketing of finished formulations. Its portfolio includes antibiotics, analgesics, and gastrointestinal treatments, delivered through various dosage forms such as tablets, capsules, and injectables.
Business Model
The company generates revenue through the sale of its own branded pharmaceutical products and by providing contract manufacturing services to other pharmaceutical firms. It leverages a manufacturing facility to serve both domestic and international markets.
Growth Outlook
Growth is expected to be driven by the expansion of its generic medicine distribution network and the strengthening of its export business in developing regions. The company continues to focus on maintaining quality standards to support these market initiatives.
Key Risks
- Regulatory Compliance. The company faces risks related to stringent quality standards and potential regulatory audits in both domestic and international markets.
- Market Competition. As a small-cap entity, the company operates in a highly competitive pharmaceutical sector with significant pressure on pricing and margins.
- Export Dependency. Fluctuations in demand or geopolitical instability in developing regions could adversely impact the company's export-oriented revenue streams.
- Raw Material Costs. Volatility in the prices of active pharmaceutical ingredients and other raw materials may affect manufacturing costs and profitability.
Start your research today
Unlock AI insights, financials, peers and live data on Zenith Health Care Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹11 Cr
TTM · standalone
NET PROFIT
₹0.72 Cr
TTM · standalone
EPS
₹0.14
TTM · standalone
RETURN ON EQUITY
9.7%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
12.4%
TTM · standalone
P/E
22.5x
Q4 FY26 · standalone
EV/EBITDA
14.3x
Q4 FY26 · standalone
EBITDA MARGIN
11.2%
TTM · standalone
NET PROFIT MARGIN
13.0%
Q4 FY26 · standalone
DEBT TO EQUITY
0.0x
Q4 FY26 · standalone
Peers · Pharmaceuticals
As of Q4 FY26